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introduction: Behavioral addictions such as gambling, sun-tanning, shopping, Internet 
use, work, exercise, or even love and sex are frequent, and share many characteristics 
and common neurobiological and genetic underpinnings with substance addictions (i.e., 
tolerance, withdrawal, and relapse). Recent literature suggests that both non-suicidal 
self-injury (NSSI) and suicidal behavior (SB) can also be conceptualized as addictions. 
The major aim of this mini review is to review the literature and explore the neurobiolog-
ical and psychological mechanisms underlying the addiction to self-harming behaviors.
Method: This is a narrative review. The authors performed literature searches in PubMed 
and Google for suicidal behavior, self-harming, addiction, and “major repeaters.” Given 
the scarce literature on the topic, a subset of the most closely related studies was 
selected. The authors also focused on three empirical studies testing the hypothesis 
that major repeaters (individuals with ≥5 lifetime suicide attempts) represent a distinctive 
suicidal phenotype and are the individuals at risk of developing an addiction to SB.
Results: The authors reviewed the concept of behavioral addictions and major repeat-
ers, current empirical evidence testing concerning whether or not NSSI and SB can be 
understood as “addictions,” and the putative mechanisms underlying them.
Conclusion: Our review suggests that both NSSI and SB can be conceptualized as 
addictions. This is relevant because if some individual’s self-harming behaviors are better 
conceptualized as an addiction, treatment approaches could be tailored to this addiction.
Keywords: suicidal behavior, non-suicidal self-injury, addiction, stress, opioid, dopamine
inTRODUCTiOn
Behavioral addictions can be defined “as a process whereby a behavior […] is employed in a pattern 
characterized by loss of control and continuation despite significant negative consequences […]” 
(1). They are frequent, and share many characteristics and common neurobiological and genetic 
underpinnings with substance addictions (i.e., tolerance, withdrawal, and relapse) (2). Behavioral 
addictions include activities such as gambling, sun-tanning, shopping, Internet use, work, exercise, 
or even love and sex (3–10). Recent literature suggests that both repetitive non-suicidal self-injury 
(NSSI) and suicidal behavior (SB) could also be understood as “addictive behaviors” in some indi-
viduals (11–16). If confirmed, this might change the way we currently treat repetitive self-harming 
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behaviors. For instance, in the same vein as alcoholics are 
treated with naltrexone, individuals characterized by repetitive 
self-harming behaviors could benefit from treatment regimens 
traditionally used for substance dependence. The present mini 
review is aimed at briefly examining the literature on this topic.
MeTHODS
Initially, the authors performed literature searches in PubMed for 
suicidal behavior, self-harming, addiction, and “major repeaters.” 
Given that there was not a single reference, we expanded our 
search to Google. We found just one reference by Ken Tullis. 
Later on, we also included PubMed and Google searches on self-
harming and addiction. Given the scarce literature on the topic, a 
subset of the studies most closely related to our aim was selected. 
The authors also focused on three empirical studies testing the 
hypothesis published in 2012 by Blasco-Fontecilla (see later) that 
major repeaters (individuals with ≥5 lifetime suicide attempts) 
represent a distinctive suicidal phenotype and are the individuals 
at risk of developing an addiction to SB.
ReSULTS
non-Suicidal Self-injury as a Behavioral 
Addiction
There is substantive theoretical literature suggesting that NSSI can 
be understood as a behavioral addiction, but very few empirical 
studies testing this compelling hypothesis exist (16). For instance, 
Faye suggested that the emotional state preceding NSSI is similar 
to the aversive withdrawal symptoms experienced by drug users 
(17). Washburn et  al. also reported that individuals displaying 
NSSI often have strong urges to self-injure (18). Furthermore, 
some authors have reported that endogenous opioids are reduced 
in individuals who engage in NSSI, but evidence contradicting 
this hypothesis is also found [see Victor et al. (16), for a review]. In 
2002, Nixon et al. (15) explored whether NSSI could be explained 
under an addictive paradigm in adolescents displaying repetitive 
NSSI. They developed a self-report measure, adapted from the 
DSM-IV criteria for substance dependence, and reported that 
81% endorsed more than five criteria. Victor et al. (16) stressed 
that, whereas both negative and positive reinforcement sustain 
substance use, “only negative reinforcement perpetuates NSSI.” 
These authors were of the opinion that the repetition of NSSI 
was better explained by emotional processes than by addiction 
mechanisms.
Suicidal Behavior as a Behavioral 
Addiction
As for suicidal behavior, in 1998, Tullis proposed a theory of suicide 
addiction (19). He described individuals addicted to SB as having 
three characteristics: (1) childhood trauma, (2) mood disorders, 
and (3) multiple addictions. Until recently, the only study that 
empirically supported this hypothesis was a report of three cases 
(20). In 2012, we proposed that some suicide attempters (major 
repeaters, individuals with ≥5 lifetime suicide attempts) were 
indeed the individuals addicted to SB (14). The characterization 
of major repeaters has been a neglected area of research (12). In 
a seminal paper, Kreitman and Casey studied over 3,000 par-
asuicides. They arbitrarily divided individuals into “first-evers” 
(those with no previous parasuicide), “minor repeaters” (those 
with a lifetime history of 2–4 parasuicides), and “major or grand 
repeaters” (those with ≥5 lifetime parasuicides) (21). They also 
warned that the variables associated with “minor repetition” were 
not necessarily the same related to “major repetition” (21). Major 
repeaters represent around 10% of all suicide attempters (21–23). 
They are heavy consumers of health resources, pose a challenge 
to clinicians (21), and are at higher risk of suicide completion (24, 
25). Later on, we tried to empirically test our hypothesis in a series 
of different samples (11–14).
In a first study, we aimed at better characterizing major 
repeaters and testing whether they represent a distinctive sui-
cidal phenotype; compared with 335 non-major repeaters (<5 
suicide attempts), major repeaters (n =  35) were more likely 
to be female, diagnosed with anorexia nervosa or substance 
dependence, and to have higher levels of trait anger with lower 
expression of anger (12).
In a second study, we demonstrated that, compared to non-
major repeaters (n =  71), major repeaters (n =  11, 13%) more 
frequently endorsed automatic positive reinforcement (“To feel 
something, because you felt numb or empty”) as a way to explain 
their SB. In this study, all major repeaters and 93% of the remain-
ing suicide attempters received at least one Axis I diagnosis, but 
there were no statistically significant differences between the 
groups. Borderline personality disorder was more frequently 
diagnosed among major repeaters. However, relieving emptiness 
(automatic positive reinforcement) was an important pathway, 
even more relevant than borderline personality disorder, to major 
repetition of suicide attempts in our study (11). This is important 
because, in contrast with the above-mentioned study suggesting 
that NSSI is perpetuated mainly through the removal of negative 
emotions (negative reinforcement) (16), our study suggests that 
major repetition of suicide attempts is perpetuated primarily 
through the generation of emotions (positive reinforcement; for 
instance, relieving emptiness, or raising the level of care or sup-
port from their relatives). Given that suicide attempts may replace 
self-mutilation, a type of NSSI, to regulate negative emotions in 
multiple-suicide attempters (26), it is possible that some major 
repeaters initially begin their “suicide career” with repetitive NSSI 
(negative reinforcement) and then replace it with repetitive SB 
(positive reinforcement).
In a third study, a cross-sectional study at Puerta de Hierro 
University Hospital (Madrid, Spain), we recruited 118 suicide 
attempters including 8 major repeaters (7%, all women) (13). 
We found that major repeaters “were more likely diagnosed with 
panic disorder without agoraphobia,” borderline personality dis-
order, and a history of psychiatric inpatient admission than non-
major repeaters. We explored whether or not major repeaters are 
addicted to SB by using seven criteria modified from the DSM-IV 
criteria for substance dependence: (1) tolerance, (2) withdrawal, 
(3) loss of control, (4) problems in quitting/cutting down, (5) 
much time spent using, (6) substantial reduction in activities, 
and (7) adverse physiological/physical consequences (13). Total 
dependence on SB was diagnosed if the individual had three or 
FiGURe 1 | Putative transition from repetitive nSSi to repetitive SB 
and the mechanisms involved.
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more of the seven criteria in the last 12 months. In our study, 83% 
of major repeaters met criteria for total dependence on SB, which 
is pretty similar to the 81% of individuals displaying NSSI who 
endorsed more than five dependence criteria on NSSI (15). In this 
third study, we ran a backward stepwise logistic regression model 
to provide odds ratios between major repeater status and total 
dependence corrected by confounding variables (13). The model 
selected total dependence and age as the remaining significant 
variables in the last step. In other words, our study suggested that 
major repeaters were addicted to SB, and that our finding was 
probably not explained by the presence of borderline personality 
disorder (13).
Here, it is important to refer to Stanley and colleagues; they have 
suggested that suicide attempters with a history of self-mutilation 
are a unique sub-population who use self-mutilation to deal with 
psychological pain (27). Unfortunately, their study involved 
DSM-IV, cluster B personality patients, and therefore, their 
findings could not be generalized. In any case, multiple- suicide 
attempters may use self-mutilation as a way of self-regulating 
negative emotions in the short term (26). However, in the long 
term, self-mutilating behaviors increase negative affectivity and 
become another stressor. Suicide attempts might then replace 
self-mutilation to regulate negative emotions in multiple-suicide 
attempters (26). In an adolescent study, suicide attempters, rela-
tive to suicide ideators, were less likely to display anger after a 
suicidal act (28). Figure 1 displays the putative transition from 
repetitive NSSI to repetitive SB and the mechanisms involved as 
suggested in the literature.
Putative Mechanisms of the Addictive 
Hypothesis of Self-Harming Behaviors
The addiction to self-harming behaviors can be explained either 
by neurobiological or psychological mechanisms. Regarding neuro-
biological mechanisms, if self-harming behaviors can be addictive 
in some instances, it is reasonable to think that a compromised 
functioning of the brain’s motivational systems, including the 
mesocortical dopamine reward system and the endogenous opi-
oid systems (29–31), and an overactivation of the stress system, 
are involved (29, 32). To the best of our knowledge, there are no 
studies directly relating the mesocortical reward system and self-
harming behaviors. However, some authors have recently sug-
gested that this system might be involved in the development of 
depression in a social defeat model of depression (30). Moreover, 
some authors demonstrated elevated endogenous opioid release 
following stressful events. For instance, chronic stress in mice 
produces opioid dependence (33), and prolonged mutilating 
elevates met-enkephalins (34). Given the role of psychological 
pain in suicide (35), and the growing evidence linking self-
mutilation in particular and NSSI in general with the stress and 
opioid systems (27, 36), it is reasonable to think that the relief of 
psychological pain is probably associated with endogenous opi-
oid release in the central nervous system in major repeaters. This 
opioid release may ultimately produce tolerance and addiction 
in vulnerable subjects (14). Furthermore, both acute and chronic 
stress increase the risk of using drugs (31), and corticotropin-
releasing factor (CRF) is involved in the vulnerability to drug 
withdrawal (37) and relapse (38). Indeed, gene polymorphisms 
of the CRF receptors have been related to exacerbated stress 
responses and vulnerability to develop drug addiction (39). 
Furthermore, patients displaying repetitive NSSI were more likely 
to display lower levels of adrenocorticotropic hormone (ACTH) 
measured in the morning or evening (40). In other words, the 
hypothalamic–pituitary–adrenal (HPA) stress system (CRH, 
ACTH) and opioid systems (beta-endorphins) are closely related 
(41). This is not surprising, given that ACTH and β-endorphins 
are derived from the same precursor, pro-opiomelanocortin 
(POMC) (42, 43). In sum, opioid and dopaminergic systems, 
and HPA axis, which interact in the forebrain (31, 32) and can 
be activated either by psychoactive drugs or by behaviors (44), 
are probably involved in the development of an addiction to self-
harming behaviors (Figure 2).
As for psychological mechanisms, Beck’s “sensitizing” hypoth-
esis (45) and a cathartic effect (46) are probably involved in the 
addiction to self-harming behaviors. Beck (45) suggested that 
previous SB sensitizes suicidal thoughts and behaviors, such 
that they become more autonomous and easily precipitated. As 
self-harming episodes become more easily triggered by stress-
ful life events, they also become more persistent and severe. 
Self-aggression ameliorates the emotional tension and painful 
emotions (i.e., emptiness) that precede SB (47–51). In a pilot 
fMRI study, the authors suggested that SB reduces mental pain 
(52). Beck’s “sensitizing” hypothesis of SB has gained some 
empirical support (53, 54). Furthermore, even after prolonged 
“free” periods, there is the risk of relapse, often precipitated by 
similar life events, in a way similar to that of drug addiction (55). 
The cathartic effect might be explained by either mobilization of 
interpersonal support (i.e., medical attention, caring family) (48, 
51) or emotional venting of an unbearable emotional or physical 
state (48, 50). Indeed, self-harming behaviors can be used as a 
signaling strategy within the “bargaining model” of depression; 
self-harming behaviors would be a way to impose costs to the 
social group where there is a conflict (56).
Therapeutic implications
The addictive model of self-harming might have an important 
impact in the way we treat repetitive self-harming behaviors, 
and help in reducing the economic cost associated with 
them. The most evident targets for halting the development 
of an addiction to self-harming behaviors are the opioid and 
dopaminergic systems, and the HPA axis (37). In 1989, some 
advocated for clinical trials of opiate antagonists (i.e., naltrexone 
FiGURe 2 | Basic neurobiological mechanisms involved in the addiction to self-harming.
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and buprenorphine) to treat NSSI (57). For instance, a recent 
yet unpublished controlled trial demonstrated that ultra-low-
dose sublingual buprenorphine was effective in decreasing 
suicidal ideation (58). CRF receptor antagonists, particularly 
CRF1 antagonists (i.e., antalarmin), have also shown promising 
results for the treatment of drug abuse and addiction (39). CRF1 
antagonists could have a lasting effect in blunting the elevated 
stress sensitivity in dependent individuals (39). As for the 
dopaminergic system, many animal models for self-injurious 
behavior share a compromised striatal dopamine system (59). 
Given that striatal dopamine receptors are coupled to L-type 
calcium channels, some have confirmed that calcium blockers, 
such as nifedipine, suppress self-injurious behavior in animal 
models (60).
Furthermore, any treatment alleviating psychological pain 
might also halt the development of the addiction to self-harming 
behaviors. For instance, lithium, known to have a specific “antisui-
cidal effect” (61), has an antinociceptive role probably mediated 
through the opioid system (62). In a still classic study, rats with 
brain lithium levels >0.5 mEq/L had a potentiation of endogenous 
enkephalin release (63). In another study, acute lithium enhanced 
“the morphine-induced analgesia in rats with or without chronic 
morphine treatment” (64). In any case, it is surprising that 
lithium’s putative antinociceptive action has been very poorly 
studied in the clinical arena. Moreover, medications acting on 
glutamatergic transmission, such as gabapentin, lamotrigine, 
topiramate, acamprosate, memantine, modafinil, d-cycloserine, 
and N-acetylcysteine, “are also of potential utility in the treatment 
of drug addiction, as well as various behavioral addictions such 
as pathological gambling” (65) and might also be useful in the 
treatment of addiction to self-harming behaviors.
Finally, new therapeutic pathways focused on treating either 
emptiness or psychological pain might also have a role in treat-
ing individuals addicted to self-harming behaviors. Regarding 
emptiness, some authors consider emptiness to be one of 
“the strongest precipitating factors in self-killing” (66). Quite 
surprisingly, as we have quoted before, there is little empirical 
research on the relationship between emptiness and SB (67). 
Some authors think that chronic feelings of emptiness are resist-
ant to psychopharmacological agents (68). However, the cholin-
ergic and serotonin systems might play a role in emptiness. For 
instance, some authors administered an acetylcholinesterase 
inhibitor  –  physostigmine  –  to individuals diagnosed with 
borderline personality disorder, other personality disorders, 
and healthy controls (69). Those individuals diagnosed with 
a personality disorder who displayed a depressive response 
to the physostigmine challenge were more likely to present a 
sense of emptiness. As we have previously suggested, drugs with 
anticholinergic activity, such as tricyclic or low potency antipsy-
chotics, might prove useful in treating emptiness, among others 
(67). Regarding serotonin and emptiness, in 1998, Verkes and 
colleagues (70) discovered that patients meeting the criterion 
of “chronic feelings of emptiness and boredom” had the most 
elevated platelet serotonin in a sample of 144 consecutive recur-
rent suicide attempters. They suggested that some patients with 
borderline personality disorder, particularly when displaying 
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elevated emptiness, might have a different pre-synaptic re-
uptake of serotonin. Accordingly, their response to drugs acting 
via serotonin might be different.
As for psychological (mental) pain, more than 90% of suicide 
attempters report it (11). Indeed, we have recently proposed 
that what really unifies SB is psychological pain (71). Given 
the increasing evidence that physical and psychological pain 
share common neural pathways (72, 73), why shouldn’t we 
treat psychological pain using the same drugs that we use, for 
instance, for a headache? For the same reasons that we don’t use 
opioids for a headache (i.e., tolerance, abstinence, dependence), 
we shouldn’t use opioid agonists for individuals addicted to SB. 
However, non-steroidal anti-inflammatory drugs and acetami-
nophen could, a  priori, be used. For instance, acetaminophen, 
taken during a 2-week period, reduced daily self-reported hurt 
feelings in comparison to a placebo (74, 75). Furthermore, there 
is increasing evidence that a single infusion of ketamine, an 
N-methyl-d-asparate antagonist, traditionally used as anesthetic, 
but also with analgesic properties, can lead to a rapid resolution 
of suicidal ideation in patients with treatment-resistant major 
depressive disorder (76). Moreover, we humans are a social 
species, and social peptides such as oxytocin, are involved in the 
development of different psychiatric disorders (77). Some self-
harming behaviors are displayed in response to social problems 
and stressful life events, as previously stated. Given the critical 
role of oxytocin in bonding and stress, it is not surprising to 
find that low cerebrospinal fluid (CSF) oxytocin is related to 
high intent in suicide attempters (78). The use of an intranasal 
application of oxytocin might modify behavior. We might think 
that intranasal oxytocin could be used for some patients display-
ing self-harming behaviors in the aftermath of social problems; 
however, a recent editorial skeptically warned that “The wish to 
believe in the effectiveness of intranasal oxytocin appears to be 
widespread and needs to be guarded against with skepticism and 
rigor” (79). Finally, acceptance and commitment therapy has 
also proven effective in reducing psychological pain in suicide 
attempters (80), and therefore might be useful in halting the 
development of an addiction to self-harming behaviors.
COnCLUSiOn
Our review suggests that both NSSI and SB can be conceptual-
ized as addictions. This is relevant because if some individual’s 
self-harming behaviors are better conceptualized as an addiction, 
treatment approaches could be tailored to this addiction. The 
major limitation of the present review is that, given the space 
constraints, we could not expand our review to other interest-
ing topics such as the putative role of impulsivity, a personality 
trait closely related to SB; impulsivity could be considered as 
the underpinning psychopathological substrate between mood, 
addiction, and self-injury behavior. Indeed, impulsivity has been 
proposed as the interface between mood and a number of addic-
tive behaviors (81).
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